Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace You Might Also Like Active Implants Appoints And To Board July 11, 2017 Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer Compounds June 12, 2017 Little Known Life Science Hedge Fund Dethroning Ackman's Pershing Square January 18, 2018
